Why the study?
Does the ACE gene insertion/deletion polymorphism associate with the presence and extent of coronary artery disease or myocardial infarction in patients undergoing coronary angiography?
Population
1,310 Caucasian patients (969 men, 341 women) undergoing coronary angiography
Comparison
Angiotensin I-converting enzyme gene… vs Other ACE genotypes
Design
Cross-sectional
Authors
Loading...
Supports no role for ACE DD genotyping in CAD risk assessment; leaves open validation in prospective cohorts.
Does the ACE gene insertion/deletion polymorphism associate with the presence and extent of coronary artery disease or myocardial infarction in patients undergoing coronary angiography?
The ACE insertion/deletion gene polymorphism is not associated with the prevalence or extent of coronary artery disease or myocardial infarction, indicating genotyping is not useful for individual risk assessment.
Pfohl et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: